Analyzing Ambu A/S (AMBBY) & The Competition

Ambu A/S (OTCMKTS:AMBBY) is one of 664 publicly-traded companies in the “Holding & other investment offices” industry, but how does it compare to its rivals? We will compare Ambu A/S to similar companies based on the strength of its risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings.

Earnings and Valuation

This table compares Ambu A/S and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Ambu A/S	$684.73 million	$24.09 million	100.66
Ambu A/S Competitors	$1.17 billion	$87.81 million	47.12

Ambu A/S’s rivals have higher revenue and earnings than Ambu A/S. Ambu A/S is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Ambu A/S and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	7.23%	6.80%	5.32%
Ambu A/S Competitors	-24.81%	-46.30%	-1.24%

Analyst Ratings

This is a breakdown of current ratings for Ambu A/S and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	0	1	0	3.00
Ambu A/S Competitors	126	559	858	14	2.49

As a group, “Holding & other investment offices” companies have a potential upside of 75.26%. Given Ambu A/S’s rivals higher probable upside, analysts clearly believe Ambu A/S has less favorable growth aspects than its rivals.

Institutional & Insider Ownership

54.2% of shares of all “Holding & other investment offices” companies are held by institutional investors. 25.4% of shares of all “Holding & other investment offices” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.